This ad will auto close in 10 seconds

Roche launches new breast cancer drugs in India

Swiss drug major Roche has launched in India two new medicines for treating breast cancer claiming increased survival benefit and improved quality of life for patients.

Roche steps up work on two experimental Alzheimer's drugs

Roche is to step up its research efforts on two Alzheimer`s drugs, both of which suffered setbacks in tests last year, reflecting its belief in drugs targeting protein plaques found in brains of patients with the disease.

Italy seeks 1.2 bn euros in anti-trust damages from Roche, Novartis

Italy`s health ministry is seeking 1.2 billion euros ($1.6 million) in compensation from Swiss pharma giants Novartis and Roche for the manipulation of sales of a cheap drug used to treat eye problems, Italian media reported Wednesday.

Clues to possible cure for jet lag found

Scientists have found a genetic mechanism in mice that hampers their body clock`s ability to adjust to changes in patterns of light and dark.

Roche looks to replicate cancer success with eye drugs

Positive results for Roche`s experimental eye drug should bolster its position in the multibillion-dollar-a-year market for vision loss treatments, as it looks to branch out beyond its core cancer expertise.

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG today said it won`t pursue the secondary patent for its breast cancer drug `Herceptin` in India.

Roche not to pursue patent for breast cancer drug in India

Swiss pharma major Roche Holding AG Friday said it won't pursue the secondary patent for its breast cancer drug 'Herceptin' in India.

Govt says Roche didn't follow norms for cancer drug patent

The government today said it had "treated as withdrawn" patent applications by Swiss pharma major Roche Holding for offshoot medicines of its breast cancer drug 'Herceptin' because the company did not comply with local norms.

Health Ministry submits details of `trastuzumab` to DIPP

The Health Ministry has submitted to the DIPP all the details of Swiss drug major Roche`s anti-cancer drug trastuzumab, which is among the three medicines being considered for possible issuance of a compulsory licence.

US approves new targeted breast cancer drug

The US Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumour cells while sparing healthy ones.

Roche says data in hepatitis treatment encouraging

Swiss drugmaker Roche said on Thursday initial data on a protease inhibitor, danoprevir, is encouraging against Hepatitis C.

Roche set to walk away from $6.8 bn Illumina bid

Swiss drugmaker Roche said on Wednesday it would not extend a $6.8 billion hostile offer for genetic specialist Illumina.

Roche to file T-DM1 breast cancer drug on good data

Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental "armed antibody" drug without the disease worsening.

Roche to sell cheaper cancer drugs in India

Swiss drugmaker Roche Holding AG plans to offer cut-price versions of two blockbuster cancer drugs for the Indian market soon, a company spokesman said on Friday, days after New Delhi moved to slash the price of a rival cancer treatment.

Roche to slash prices of expensive cancer drugs in India

Global pharma major Roche is all set to slash the price of two expensive cancer drugs in India, as part of efforts to strengthen its position amid rising competition from generic drug makers, says a media report.

Roche issues counterfeit cancer drug warning

Counterfeit versions of the cancer-fighting drug Avastin have been discovered in circulation in US.

Roche benefits from Tamiflu sales as Q3 shines

Roche`s (ROG.VX) third-quarter sales rose 10 percent to 12.4 billion Swiss francs ($12.2 billion), helped by its cancer drugs and increased demand for flu medicine Tamiflu due to the H1N1 pandemic.

SC refuses relief to Roche on patent plea against Cipla

The Supreme Court Friday refused to give any relief to Swiss pharma firm Hoffman La Roche Ltd that had challenged a Delhi High Court order allowing Cipla to manufacture and sell a generic version of lung cancer drug `Erlotinib`.